Joaquin Duato
Joaquin Duato is the Chief Executive Officer of Johnson & Johnson, one of the world's largest pharmaceutical and medical device companies. He has been vocal about the potential impacts of US tariffs on the pharmaceutical industry, warning that such measures could lead to drug shortages and disrupt supply chains. Duato advocates for tax policy as a more effective means of boosting domestic manufacturing rather than tariffs. Under his leadership, J&J has committed to significant investments in US manufacturing.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 6.00 | 0.08% | +0% | 8,654,622 | 6,985 | $700,000 | 565$ |
| Totals | 1 | 8,654,622 | 6,985 | $700,000 | 565$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Joaquin Duato, the CEO of Johnson & Johnson, announced ambitious revenue goals in the oncology market.
6
Ireland:
Joaquin Duato is the chief executive of J&J who spoke with Taoiseach Micheál Martin about tariffs.
5
Australia:
Joaquin Duato is the CEO of Johnson & Johnson and expects game-changing approvals in the second half of 2025.
9
United Kingdom:
He introduced CEOs of major companies, including Johnson & Johnson's Joaquin Duato.
5
United States:
Johnson & Johnson, under CEO Joaquin Duato, will invest $55 billion in new manufacturing and technology upgrades.
8
Spain:
Joaquín Duato is the president and CEO of Johnson & Johnson, earning 24.3 million dollars.
7
Spain:
Joaquín Duato, president and CEO of Johnson & Johnson, earned 24.3 million dollars last year.
7
Ireland:
Joaquin Duato, who leads one of the world’s biggest pharma and medical device companies, warned that pharmaceutical tariffs could create disruptions in the supply chain.
7